Publicacions en què col·labora amb FRANCISCO VIVES MONTERO (14)

2022

  1. Aminopeptidase Activities Interact Asymmetrically between Brain, Plasma and Systolic Blood Pressure in Hypertensive Rats Unilaterally Depleted of Dopamine

    Biomedicines, Vol. 10, Núm. 10

  2. Asymmetric Interaction of Neuropeptidase Activities between Cortico-Limbic Structures, Plasma and Cardiovascular Function after Unilateral Dopamine Depletions of the Nigrostriatal System

    Biomedicines, Vol. 10, Núm. 2

2019

  1. Asymmetrical response of aminopeptidase A in the medial prefrontal cortex and striatum of 6-OHDA-unilaterally-lesioned Wistar Kyoto and spontaneously hypertensive rats

    Pharmacology Biochemistry and Behavior, Vol. 182, pp. 12-21

2017

  1. Bilateral distribution of enkephalinase activity in the medial prefrontal cortex differs between WKY and SHR rats unilaterally lesioned with 6-hydroxydopamine

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 75, pp. 213-218

2016

  1. Handedness and gender influence blood pressure in young healthy men and women: A pilot study

    Endocrine Regulations, Vol. 50, Núm. 1, pp. 10-15

2015

  1. Serum pyroglutamyl aminopeptidase activity: A promising novel biomarker candidate for liver cirrhosis

    Endocrine Regulations, Vol. 49, Núm. 1, pp. 20-24

2011

  1. Blood pressure increased dramatically in hypertensive rats after left hemisphere lesions with 6-hydroxydopamine

    Neuroscience Letters, Vol. 500, Núm. 2, pp. 148-150

  2. Oxidative stress and aminopeptidases in Parkinson's disease patients with and without treatment

    Neurodegenerative Diseases, Vol. 8, Núm. 3, pp. 109-116

2010

  1. Oxidative stress and plasma aminopeptidase activity in Huntington's disease

    Journal of Neural Transmission, Vol. 117, Núm. 3, pp. 325-332

  2. Plasma α-synuclein in patients with Parkinson's disease with and without treatment

    Movement Disorders, Vol. 25, Núm. 4, pp. 489-493

2009

  1. Asymmetrical response of aminopeptidase A and nitric oxide in plasma of normotensive and hypertensive rats with experimental hemiparkinsonism

    Neuropharmacology, Vol. 56, Núm. 3, pp. 573-579

2006

  1. Plasma aminopeptidase activities in Parkinson's disease

    Hormone and Metabolic Research, Vol. 38, Núm. 11, pp. 758-760

2005

  1. Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)

    Pharmacogenomics Journal, Vol. 5, Núm. 2, pp. 135-141

2000

  1. Comparative effects of melatonin, L-deprenyl, trolox and ascorbate in the suppression of hydroxyl radical formation during dopamine autoxidation in vitro

    Journal of Pineal Research, Vol. 29, Núm. 2, pp. 100-107